591 related articles for article (PubMed ID: 16527440)
1. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
2. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
[TBL] [Abstract][Full Text] [Related]
4. Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis.
Omari MM; Badwan AA; Zughul MB; Eric J; Davies D
Drug Dev Ind Pharm; 2007 Nov; 33(11):1205-15. PubMed ID: 18058317
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
6. Biquinolino-modified beta-cyclodextrin dimers and their metal complexes as efficient fluorescent sensors for the molecular recognition of steroids.
Liu Y; Song Y; Chen Y; Li XQ; Ding F; Zhong RQ
Chemistry; 2004 Aug; 10(15):3685-96. PubMed ID: 15281152
[TBL] [Abstract][Full Text] [Related]
7. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamics of propylparaben/beta-cyclodextrin inclusion complexes.
Zughul MB; al-Omari M; Badwan AA
Pharm Dev Technol; 1998 Feb; 3(1):43-53. PubMed ID: 9532599
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments.
Segura-Sanchez F; Bouchemal K; Lebas G; Vauthier C; Santos-Magalhaes NS; Ponchel G
J Mol Recognit; 2009; 22(3):232-41. PubMed ID: 19153981
[TBL] [Abstract][Full Text] [Related]
10. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
Sun DZ; Li L; Qiu XM; Liu F; Yin BL
Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
[TBL] [Abstract][Full Text] [Related]
11. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic studies of inclusion complex of beta-cyclodextrin and benzidine diammonium dipicrate.
Hamdi H; Abderrahim R; Meganem F
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jan; 75(1):32-6. PubMed ID: 19879800
[TBL] [Abstract][Full Text] [Related]
16. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
17. Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and (1)H NMR spectroscopy.
Danel C; Azaroual N; Brunel A; Lannoy D; Vermeersch G; Odou P; Vaccher C
J Chromatogr A; 2008 Dec; 1215(1-2):185-93. PubMed ID: 19013582
[TBL] [Abstract][Full Text] [Related]
18. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
[TBL] [Abstract][Full Text] [Related]
19. Factors controlling the complex architecture of native and modified cyclodextrins with dipeptide (Z-Glu-Tyr) studied by microcalorimetry and NMR spectroscopy: critical effects of peripheral bis-trimethylamination and cavity size.
Yamamura H; Rekharsky MV; Ishihara Y; Kawai M; Inoue Y
J Am Chem Soc; 2004 Nov; 126(43):14224-33. PubMed ID: 15506789
[TBL] [Abstract][Full Text] [Related]
20. Characterization, phase solubility and molecular modeling of alpha-cyclodextrin/pyrimethamine inclusion complex.
de Araujo MV; Macedo OF; Nascimento Cda C; Conegero LS; Barreto LS; Almeida LE; da Costa NB; Gimenez IF
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Feb; 72(1):165-70. PubMed ID: 19019728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
